Gastrointestinal stromal tumor after tyrosine kinase inhibition therapy: a review of biopsies of 34 patients with clinically suspected relapse and/or progression of the tumor. | Neoplasma;64(3): 464-473, 2017. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Gastrointestinal stromal tumor after tyrosine kinase inhibition therapy: a review of biopsies of 34 patients with clinically suspected relapse and/or progression of the tumor.

Plank, L; Buzalkova, V; Szepe, P; Lasabova, Z; Jasek, K; Stanclova, A; Minarik, G; Sufliarsky, J.

Neoplasma ; 64(3): 464-473, 2017.

Article in En | MEDLINE | ID: mdl-28253727

Subject(s)
Key words

PDGFRA mutations; c-KIT mutations; gastrointestinal stromal tumor; targeted therapy postherapeutical changes.; tyrosine kinase inhibition

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Protein Kinase Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neoplasma Year: 2017 Document type: Article Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Protein Kinase Inhibitors Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neoplasma Year: 2017 Document type: Article Country of publication: